Journals / Experimental Biomedical Research / 2021 / Cilt: 4 - Sayı: 2

Alginate encapsulation induce colony formation with umbilical cord-derived mesenchymal stem cells

Pages
113–121
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: In the study, it was found that the most effective method was the alginate sphere form and that the structure of the cells should be preserved by injecting them into biomaterials in encapsulation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The umbilical cord (UC) is a rich source of mesenchymal stem cell (MSC) isolation.
📊
Key Findings & Data:Methods: The cell viability, live/dead cell ratio, and colony formation capacities of the encapsulated cells were examined for 14 days.
💡
Conclusion & Impact:Results: In the study, it was found that the most effective method was the alginate sphere form and that the structure of the cells should be preserved by injecting them into biomaterials in encapsulation.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: The umbilical cord (UC) is a rich source of mesenchymal stem cell (MSC) isolation. Since the MSCs isolated from here have high self-renewal capacity and differentiation potential, production through biofabrication is essential for clinical treatments. For the cells to be stored for a long time and presented ready for use, encapsulation is required. In this study, UC-MSC cells were encapsulated with alginate using three different methods: alginate drop, alginate coating, and alginate sphere. Methods: The cell viability, live/dead cell ratio, and colony formation capacities of the encapsulated cells were examined for 14 days. Results: In the study, it was found that the most effective method was the alginate sphere form and that the structure of the cells should be preserved by injecting them into biomaterials in encapsulation. Colony formation potential was found to be high in biomaterials with alginate spheres. Conclusion: As a result, the preservation of UC-MSC cells with alginate sphere encapsulation via biofabrication and their clinical use availability may be beneficial for treating of many diseases.

🔖

Cite This Article

GÜMÜŞ, E., ABAS, B., ÇEVİK, E., KOCABIYIK, B., CENİK, M., ÇEVİK, Ö. (2021). Alginate encapsulation induce colony formation with umbilical cord-derived mesenchymal stem cells. Experimental Biomedical Research, Cilt: 4 - Sayı: 2, 113–121. https://ajindex.com/articles/210825

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012
  2. 12(5):383–96. [2]Diekman B, Wu C-L, Louer C, et al. Intraarticular Delivery of Purified Mesenchymal Stem Cells From C57BL/6 or MRL/MpJ Superhealer Mice Prevents Posttraumatic Arthritis. Cell Transplant. 2013
  3. 22(8):1395- 408. [3]Pers Y-M, Rackwitz L, Ferreira R, et al. Adipose Mesenchymal Stromal Cell-Based Therapy for Severe Osteoarthritis of the Knee: A Phase I Dose-Escalation Trial. Stem Cells Transl Med. 2016
  4. 5(7):847–56. [4]Harrell C, Fellabaum C, Jovicic N, et al. Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome. Cells. 201
  5. 8(5):467. [5]Wagner B, Henschler R. Fate of Intravenously Injected Mesenchymal Stem Cells and Significance for Clinical Application. Adv Biochem Eng Biotechnol. 2013
  6. Hmadcha A, Martin-Montalvo A, Gauthier BR, et al. Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy. Front Bioeng Biotechnol. 2020
  7. Van Pham P. Stem cell drugs: the next generation of pharmaceutical products. Biomed Res Ther. 2016
  8. 3(10):857-71. [8]Selich A, Zimmermann K, Tenspolde M, et al. Umbilical cord as a long-Term source of activatable mesenchymal stromal cells for immunomodulation. Stem Cell Res Ther. 2019
  9. 10(1):285. [9]Chen M-Y, Lie P-C, Li Z-L, et al. Endothelial differentiation of Wharton’s jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp Hematol. 2009
  10. 37(5):629–40. [10]Hendijani F, Sadeghi-Aliabadi H, Javanmard S. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton’s jelly matrix. Cell Tissue Bank. 2014
  11. 5(4):555-65. [11]Leijs MJ, Villafuertes E, Haeck JC, et al. Encapsulation of allogeneic mesenchymal stem cells in alginate extends local presence and therapeutic function. Eur Cell Mater. 2017
  12. 43–58. [12]Hunt NC, Smith AM, Gbureck U, et al. Encapsulation of fibroblasts causes accelerated alginate hydrogel degradation. Acta Biomater. 2010
  13. 6(9):3649-56. [13]Orive G, Hernández RM, Gascón AR, et al. History, Challenges and Perspectives of Cell Microencapsulation. Trends Biotechnol. 2004
  14. 22(2):87-92. [14]Cevik O, Turut FA, Acidereli H, et al. Cyclosporine-A induces apoptosis in human prostate cancer cells PC3 and DU145 via downregulation of COX-2 and upregulation of TGFβ. Turkish J Biochem. 2019
  15. 44(1):47-54. [15]Murray IR, Ch